Alexander V Louie
Overview
Explore the profile of Alexander V Louie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
225
Citations
5126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lehrer E, Khunsriraksakul C, Garrett S, Trifiletti D, Sheehan J, Guckenberger M, et al.
Crit Rev Oncol Hematol
. 2025 Jan;
208:104631.
PMID: 39864534
There is much debate regarding optimal selection in patients with metastatic cancer who should undergo local treatment (surgery or radiation treatment) to the primary tumor and/or metastases. Additionally, the optimal...
2.
Nguyen T, Louie A, Kotecha R, Saxena A, Zhang Y, Guckenberger M, et al.
Radiother Oncol
. 2025 Jan;
205:110717.
PMID: 39862925
Background: While SBRT to NSBM has become common, particularly in the oligometastatic population, the approach to treating non-spine bone metastases (NSBM) with stereotactic body radiotherapy (SBRT) varies widely across institutions...
3.
Cheema P, Wheatley-Price P, Cecchini M, Ellis P, Louie A, Moore S, et al.
Curr Oncol
. 2024 Nov;
31(11):6979-6999.
PMID: 39590145
Therapeutic strategies for early-stage non-small cell lung cancer (NSCLC) are advancing, with immune checkpoint inhibitors (ICIs) and targeted therapies making their way into neoadjuvant and adjuvant settings. With recent advances,...
4.
David Wu C, Wierzbicki M, Parpia S, Kundapur V, Bujold A, Filion E, et al.
Radiother Oncol
. 2024 Oct;
202:110605.
PMID: 39481606
Background And Purpose: Stereotactic body radiotherapy (SBRT) carries potentially higher risks for ultracentral (UC) NSCLC with limited prospective data to guide decision making. We conducted a secondary analysis from a...
5.
Franzese C, Louie A, Kotecha R, Zhang Z, Guckenberger M, Kim M, et al.
Pract Radiat Oncol
. 2024 Oct;
PMID: 39419281
Purpose: Liver metastases are a significant clinical challenge in cancer management, often representing a stage of disease in which curative treatment is still possible. Stereotactic body radiation therapy (SBRT) has...
6.
Tsao M, Ung Y, Cheung P, Poon I, Louie A
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39410003
Introduction: This systematic review evaluated whether curative intent hypofractionated radiation therapy improved survival (primary endpoint) as compared to standard conventionally fractionated radiation therapy for stage III non-small cell lung cancer...
7.
Fan K, Jerzak K, Kumar S, Moravan V, Said B, Das S, et al.
J Neurooncol
. 2024 Oct;
171(1):65-73.
PMID: 39365544
Purpose: In patients with oligometastatic disease (OMD) treated with stereotactic body radiation therapy (SBRT), those who develop brain metastases (BrM) may have poor outcomes. We aimed to investigate variables associated...
8.
Tan V, Correa R, Nguyen T, Louie A, Malthaner R, Fortin D, et al.
Int J Radiat Oncol Biol Phys
. 2024 Oct;
121(1):39-44.
PMID: 39362312
Purpose: For early-stage non-small cell lung cancer, surgery is the preferred approach in operable patients, whereas SABR is preferred for patients who are medically inoperable. The combination of neoadjuvant SABR...
9.
Correa R, Louie A, Siva S
Eur Urol Oncol
. 2024 Sep;
7(6):1164-1165.
PMID: 39343638
No abstract available.
10.
Swaminath A, Parpia S, Wierzbicki M, Kundapur V, Faria S, Okawara G, et al.
JAMA Oncol
. 2024 Sep;
10(11):1571-1575.
PMID: 39298144
Importance: Stereotactic body radiotherapy (SBRT) is widely used for stage I medically inoperable non-small cell lung cancer (NSCLC), yet varied results from randomized clinical trials (RCTs) and concerns in treating...